---
title: Nimesulide + Tinidazole
description: >-
  This combination medication is prescribed for the treatment of various
  infections and associated pain and inflammation. Nimesulide is a non-steroidal
  anti-inflammatory drug (NSAID), while Tinidazole is an antiprotozoal and
  antibacterial agent.  It is commonly used to treat:
is_banned: false
lastModified: '2025-09-22T17:22:09.616Z'
faqs:
  - q: >-
      What is the recommended dosage for Nimesulide + Tinidazole?**


      **A:** The typical adult dose is 100 mg Nimesulide + 200 mg Tinidazole
      twice daily, after meals.  Pediatric doses of Tinidazole must be
      calculated based on the child's weight and specific infection. Nimesulide
      is contraindicated in children under 12.
    a: >-
      A:** The typical adult dose is 100 mg Nimesulide + 200 mg Tinidazole twice
      daily, after meals.  Pediatric doses of Tinidazole must be calculated
      based on the child's weight and specific infection. Nimesulide is
      contraindicated in children under 12.
  - q: >-
      What are the primary uses of this combination?**


      **A:** It's used for managing infections accompanied by pain and
      inflammation, particularly in dental, gynecological, and intra-abdominal
      infections.  Also for parasitic infections.
    a: >-
      A:** It's used for managing infections accompanied by pain and
      inflammation, particularly in dental, gynecological, and intra-abdominal
      infections.  Also for parasitic infections.
  - q: >-
      What are the main contraindications?**


      **A:**  Hypersensitivity, active peptic ulcers, severe liver/kidney
      disease, heart failure, pregnancy, breastfeeding, and in children under 12
      for Nimesulide.
    a: >-
      A:**  Hypersensitivity, active peptic ulcers, severe liver/kidney disease,
      heart failure, pregnancy, breastfeeding, and in children under 12 for
      Nimesulide.
  - q: >-
      What are the most common side effects?**


      **A:**  Nausea, vomiting, diarrhea, dizziness, headache, skin rash,
      itching, heartburn.
    a: >-
      A:**  Nausea, vomiting, diarrhea, dizziness, headache, skin rash, itching,
      heartburn.
  - q: >-
      Are there any serious side effects to be aware of?**


      **A:** Yes, rare but serious side effects include severe skin reactions,
      liver damage, blood disorders, and gastrointestinal bleeding.
    a: >-
      A:** Yes, rare but serious side effects include severe skin reactions,
      liver damage, blood disorders, and gastrointestinal bleeding.
  - q: >-
      Can this combination be used in pregnancy or breastfeeding?**


      **A:**  No, it is contraindicated in both pregnancy, especially first
      trimester for Tinidazole and third for Nimesulide, and breastfeeding.
    a: >-
      A:**  No, it is contraindicated in both pregnancy, especially first
      trimester for Tinidazole and third for Nimesulide, and breastfeeding.
  - q: >-
      What are the potential drug interactions?**


      **A:**  Nimesulide interacts with anticoagulants, antihypertensives, and
      lithium. Tinidazole interacts with alcohol, disulfiram, warfarin, lithium,
      phenytoin, and drugs metabolized by CYP3A4.
    a: >-
      A:**  Nimesulide interacts with anticoagulants, antihypertensives, and
      lithium. Tinidazole interacts with alcohol, disulfiram, warfarin, lithium,
      phenytoin, and drugs metabolized by CYP3A4.
  - q: >-
      What precautions should be taken when prescribing this medication?**


      **A:** Pre-screen for allergies, liver/kidney dysfunction, and
      cardiovascular disease. Advise patients to avoid alcohol with Tinidazole.
      Monitor for adverse reactions, especially liver function. Consider dose
      adjustments in elderly patients and those with renal impairment. Avoid in
      children under 12.
    a: >-
      A:** Pre-screen for allergies, liver/kidney dysfunction, and
      cardiovascular disease. Advise patients to avoid alcohol with Tinidazole.
      Monitor for adverse reactions, especially liver function. Consider dose
      adjustments in elderly patients and those with renal impairment. Avoid in
      children under 12.
  - q: >-
      What is the mechanism of action for each component?**


      **A:**  Nimesulide inhibits COX-2, reducing inflammation. Tinidazole
      damages microbial DNA, leading to cell death.
    a: >-
      A:**  Nimesulide inhibits COX-2, reducing inflammation. Tinidazole damages
      microbial DNA, leading to cell death.
---
## **Usage**

This combination medication is prescribed for the treatment of various infections and associated pain and inflammation. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID), while Tinidazole is an antiprotozoal and antibacterial agent.  It is commonly used to treat:

*   Infections of the gums, teeth, and oral cavity.
*   Gynecological infections, including vaginitis and pelvic inflammatory disease.
*   Intra-abdominal infections.
*   Parasitic infections such as giardiasis and amebiasis.

**Pharmacological Classification:**

*   Nimesulide: Non-steroidal anti-inflammatory drug (NSAID)
*   Tinidazole: Antiprotozoal, antibacterial (nitroimidazole class)

**Mechanism of Action:**

*   Nimesulide:  Preferentially inhibits cyclooxygenase-2 (COX-2) enzyme, reducing the production of prostaglandins, which are mediators of pain and inflammation.  It has some COX-1 inhibitory activity as well.
*   Tinidazole: Interacts with microbial DNA, causing strand breakage and inhibiting nucleic acid synthesis, leading to cell death.

## **Alternate Names**

While Nimesulide + Tinidazole is the generic name, many brand names exist internationally. Some of the common brand names include Nimzone MR, Mytiz, Nimdad Forte MR, and Nimuram T.

## **How It Works**

**Pharmacodynamics:**

Nimesulide reduces inflammation, pain, and fever by primarily inhibiting COX-2 and reducing prostaglandin production. Tinidazole is active against a wide range of protozoa and anaerobic bacteria by disrupting DNA synthesis and integrity.

**Pharmacokinetics:**

*   **Absorption:** Nimesulide is rapidly and almost completely absorbed after oral administration. Tinidazole has good oral bioavailability, reaching peak plasma concentrations within about 2 hours.
*   **Metabolism:** Nimesulide is extensively metabolized in the liver, primarily by hydroxylation to 4-hydroxynimesulide (which is also active), and glucuronidation. Tinidazole is primarily metabolized in the liver by oxidation and glucuronidation.
*   **Elimination:** Nimesulide metabolites are excreted mainly in the urine, with some biliary excretion. Tinidazole is excreted in the urine (60-70%) and feces.

**Mode of Action:**

*   **Nimesulide:** Binds to and inhibits COX-2, reducing prostaglandin synthesis, with weaker inhibition of COX-1.
*   **Tinidazole:** Enters microbial cells and reduces the nitro group of the imidazole ring.  This leads to the formation of cytotoxic radicals which disrupt DNA and protein synthesis leading to microbial cell death.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

The typical adult dose is 100 mg of Nimesulide and 200 mg of Tinidazole, taken twice daily after meals.  The maximum duration of treatment should not generally exceed 15 days.


#### **Children:**

Nimesulide is contraindicated in children under 12 years of age. Tinidazole dosing in children varies depending on the infection being treated; it's usually calculated based on body weight (50 mg/kg/day in divided doses). Pediatric guidelines should be consulted for appropriate dosage. For combination therapy, a pediatrician should determine the appropriate dosage.


#### **Special Cases:**

*   **Elderly Patients:** Caution should be exercised; dosage adjustment may be necessary.
*   **Patients with Renal Impairment:** Caution is advised. Dose reductions are usually necessary in moderate to severe impairment.
*   **Patients with Hepatic Dysfunction:** Nimesulide is contraindicated. Tinidazole requires dosage reduction.
*   **Patients with Comorbid Conditions:** Caution should be exercised in patients with cardiovascular disease, diabetes, or gastrointestinal disorders.


### **Clinical Use Cases**

This combination is generally not indicated for intubation, surgical procedures, mechanical ventilation, intensive care unit (ICU) use, or emergency situations.

### **Dosage Adjustments**

Dose modifications may be necessary based on renal or hepatic dysfunction, other medical conditions, or concomitant medications. Always consult specific guidelines and clinical judgment.



## **Side Effects**

### **Common Side Effects**

Nausea, vomiting, diarrhea, dizziness, headache, rash, itching, and heartburn.

### **Rare but Serious Side Effects**

Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), hepatotoxicity (liver damage, including liver failure), blood disorders (thrombocytopenia, leukopenia, pancytopenia), gastrointestinal bleeding, and allergic reactions.

### **Long-Term Effects**

Long-term use of Nimesulide carries the risk of renal impairment, gastrointestinal ulceration, and cardiovascular complications. Chronic use of Tinidazole can rarely result in peripheral neuropathy.


### **Adverse Drug Reactions (ADR)**

Any signs of hepatotoxicity, blood disorders, or severe skin reactions should prompt immediate discontinuation of the drug and appropriate medical intervention.

## **Contraindications**

Hypersensitivity to nimesulide, tinidazole, or other NSAIDs; active peptic ulcer disease; severe hepatic impairment; severe renal impairment; severe heart failure; pregnancy (especially first trimester for Tinidazole and third trimester for Nimesulide); breastfeeding; children under 12 years of age (for Nimesulide).

## **Drug Interactions**

Nimesulide can interact with anticoagulants (warfarin), antihypertensives, lithium, and other NSAIDs. Tinidazole can interact with alcohol, disulfiram, warfarin, lithium, phenytoin, and other drugs metabolized by CYP3A4 enzymes.

## **Pregnancy and Breastfeeding**

Contraindicated in pregnancy (especially the first trimester for Tinidazole and third trimester for Nimesulide) and breastfeeding. Both drugs can cross the placenta and are excreted in breast milk. Safer alternatives should be considered.

## **Drug Profile Summary**

*   **Mechanism of Action:**  Nimesulide inhibits COX-2 primarily, reducing inflammation; Tinidazole disrupts microbial DNA.
*   **Side Effects:** Nausea, vomiting, diarrhea, dizziness, headache, rash, itching, potentially severe liver damage, and blood disorders.
*   **Contraindications:** Hypersensitivity, active peptic ulcer, severe liver or renal impairment, heart failure, pregnancy, breastfeeding, children under 12 (Nimesulide).
*   **Drug Interactions:** Anticoagulants, antihypertensives, alcohol, disulfiram, and other drugs metabolized by the liver.
*   **Pregnancy & Breastfeeding:** Contraindicated.
*   **Dosage:** Adults: Nimesulide 100mg + Tinidazole 200mg twice daily.  Children: Nimesulide contraindicated, Tinidazole dosing weight-based.
*   **Monitoring Parameters:** Liver function tests, renal function, complete blood counts, and signs of gastrointestinal bleeding.

## **Popular Combinations**

This specific combination is not very popular, rather specific individual drugs with others is common.

## **Precautions**

Screen for allergies, hepatic and renal dysfunction, cardiovascular disease, and other relevant medical conditions. Avoid alcohol during treatment and for 3 days after the last dose of Tinidazole. Exercise caution in the elderly and patients with renal impairment.  Nimesulide should be used with caution in patients with bleeding disorders.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Nimesulide + Tinidazole?**

**A:** The typical adult dose is 100 mg Nimesulide + 200 mg Tinidazole twice daily, after meals.  Pediatric doses of Tinidazole must be calculated based on the child's weight and specific infection. Nimesulide is contraindicated in children under 12.



### **Q2: What are the primary uses of this combination?**

**A:** It's used for managing infections accompanied by pain and inflammation, particularly in dental, gynecological, and intra-abdominal infections.  Also for parasitic infections.

### **Q3: What are the main contraindications?**

**A:**  Hypersensitivity, active peptic ulcers, severe liver/kidney disease, heart failure, pregnancy, breastfeeding, and in children under 12 for Nimesulide.

### **Q4: What are the most common side effects?**

**A:**  Nausea, vomiting, diarrhea, dizziness, headache, skin rash, itching, heartburn.

### **Q5: Are there any serious side effects to be aware of?**

**A:** Yes, rare but serious side effects include severe skin reactions, liver damage, blood disorders, and gastrointestinal bleeding.

### **Q6: Can this combination be used in pregnancy or breastfeeding?**

**A:**  No, it is contraindicated in both pregnancy, especially first trimester for Tinidazole and third for Nimesulide, and breastfeeding.

### **Q7: What are the potential drug interactions?**

**A:**  Nimesulide interacts with anticoagulants, antihypertensives, and lithium. Tinidazole interacts with alcohol, disulfiram, warfarin, lithium, phenytoin, and drugs metabolized by CYP3A4.

### **Q8: What precautions should be taken when prescribing this medication?**

**A:** Pre-screen for allergies, liver/kidney dysfunction, and cardiovascular disease. Advise patients to avoid alcohol with Tinidazole. Monitor for adverse reactions, especially liver function. Consider dose adjustments in elderly patients and those with renal impairment. Avoid in children under 12.

### **Q9: What is the mechanism of action for each component?**

**A:**  Nimesulide inhibits COX-2, reducing inflammation. Tinidazole damages microbial DNA, leading to cell death.



